BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2225080)

  • 1. Thymic hormone modulation of age-induced changes in the induction of graft-versus-host disease by DBA/2J lymphocytes.
    Fast LD; Kouttab NM; Badamchian M; Goldstein AL
    Cell Immunol; 1990 Nov; 131(1):232-41. PubMed ID: 2225080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DBA/2J and DBA/2Ha lymphocytes differ in their ability to induce graft-vs-host disease.
    Fast LD
    J Immunol; 1989 Oct; 143(8):2489-93. PubMed ID: 2794505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of IL-2-activated veto cells.
    Fast LD
    J Immunol; 1992 Sep; 149(5):1510-5. PubMed ID: 1354678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a single non-H-2 gene regulating graft-versus-host disease response.
    Fast LD
    J Immunol; 1990 Jun; 144(11):4177-82. PubMed ID: 2111342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease.
    Fast LD
    J Immunol; 1991 Sep; 147(6):1731-8. PubMed ID: 1909729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
    Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
    Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
    Rozendaal L; Pals ST; Melief CJ; Gleichmann E
    Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.
    Thiele DL; Eigenbrodt ML; Bryde SE; Eigenbrodt EH; Lipsky PE
    J Clin Invest; 1989 Dec; 84(6):1947-56. PubMed ID: 2531761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
    Krenger W; Rossi S; Piali L; Holländer GA
    Blood; 2000 Jul; 96(1):347-54. PubMed ID: 10891472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease.
    Tschetter JR; Mozes E; Shearer GM
    J Immunol; 2000 Nov; 165(10):5987-94. PubMed ID: 11067962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyric acid derivative induces allospecific T cell anergy and prevents graft-versus-host disease.
    Gilbert KM; Boger S; Fifer EK
    Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):13-27. PubMed ID: 12675196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytokine expression in acute and chronic murine graft-versus-host-disease.
    Allen RD; Staley TA; Sidman CL
    Eur J Immunol; 1993 Feb; 23(2):333-7. PubMed ID: 8436168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-18 prevents the development of chronic graft-versus-host disease in mice.
    Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
    J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function.
    Soloviova K; Puliaiev M; Foster A; Via CS
    Methods Mol Biol; 2012; 900():253-70. PubMed ID: 22933073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic hormones in radiation-induced immunodeficiency. I. Induction of mature interleukin 1 responsive cell in the thymus by thymosin fraction 5.
    Neta R; MacVittie TJ; Schwartz GN; Douches SD
    Cell Immunol; 1985 Sep; 94(2):480-90. PubMed ID: 3875422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of murine chronic graft-versus-host disease by the chloroform extract of Tripterygium wilfordii Hook f.
    Asano K; Yu Y; Kasahara T; Hisamitsu T
    Transpl Immunol; 1997 Dec; 5(4):315-9. PubMed ID: 9504154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.